Product Program year 2020 Source: CMS Open Payments

Interlock

Device Embolics

Open in the dashboard

General payments

$29,454

408 payments

Research payments

$0

0 payments

Through program year 2020, $29,454 in general payments and $0 in research payments were reported against Interlock (Embolics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $6,609 150
2019 General $22,845 258

Breakdown

Who paid General payments · program years 2019–2020
  1. Boston Scientific Corporation $29,454 408 payments
Top recipients General payments · program year 2020
  1. Eric Secemsky Interventional Cardiology · Boston, MA $1,500 23% · 1 payment
  2. Michael Dudkiewicz Vascular Surgery · New York, NY $254 4% · 5 payments
  3. Armeen Mahvash Vascular & Interventional Radiology · Houston, TX $176 3% · 3 payments
  4. Ramesh Gowda Interventional Cardiology · New York, NY $171 3% · 2 payments
  5. David O'Connor Vascular Surgery · Hackensack, NJ $155 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular & Interventional Radiology Radiology $2,106 33% · 54 practitioners
  2. Interventional Cardiology Internal Medicine $1,837 29% · 5 practitioners
  3. Diagnostic Radiology Radiology $964 15% · 27 practitioners
  4. Vascular Surgery Surgery $788 12% · 14 practitioners
  5. Cardiovascular Disease Internal Medicine $173 3% · 4 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Massachusetts $1,519 23% · 2 recipients
  2. New York $1,104 17% · 11 recipients
  3. California $849 13% · 27 recipients
  4. Texas $615 9% · 10 recipients
  5. New Jersey $503 8% · 8 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

408 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record